{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:18:26Z","timestamp":1790266706859,"version":"4.1.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn\u2019s disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been generally believed that the environment, immune disorders, genetic susceptibility, and intestinal microbes are the main factors for the disease pathogenesis. With the development of the sequencing technology, microbial factors have received more and more attention. The gut microbiota is in a state of precise balance with the host, in which the host immune system is tolerant to immunogenic antigens produced by gut commensal microbes. In IBD patients, changes in the balance between pathogenic microorganisms and commensal microbes lead to changes in the composition and diversity of gut microbes, and the balance between microorganisms and the host would be disrupted. This new state is defined as dysbiosis. It has been confirmed, in both clinical and experimental settings, that dysbiosis plays an important role in the occurrence and development of IBD, but the causal relationship between dysbiosis and inflammation has not been elucidated. On the other hand, as a classic research method for pathogen identification, the Koch\u2019s postulates sets the standard for verifying the role of pathogens in disease. With the further acknowledgment of the disease pathogenesis, it is realized that the traditional Koch\u2019s postulates is not applicable to the etiology research (determination) of infectious diseases. Thus, many researchers have carried out more comprehensive and complex elaboration of Koch\u2019s postulates to help people better understand and explain disease pathogenesis through the improved Koch\u2019s postulates. Therefore, focusing on the new perspective of the improved Koch\u2019s postulates is of great significance for deeply understanding the relationship between dysbiosis and IBD. This article has reviewed the studies on dysbiosis in IBD, the use of microbial agents in the treatment of IBD, and their relationship to the modified Koch\u2019s postulates.<\/jats:p>","DOI":"10.3389\/fmed.2022.1023896","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T07:17:04Z","timestamp":1668064624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch\u2019s postulates"],"prefix":"10.3389","volume":"9","author":[{"given":"HanZheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenHui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiuPing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YueNan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanJie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease.","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","article-title":"Extraintestinal manifestations and complications in IBD.","volume":"10","author":"Ott","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China.","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/gutjnl-2012-303661","article-title":"Geographical variability and environmental risk factors in inflammatory bowel disease.","volume":"62","author":"Ng","year":"2013","journal-title":"Gut."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art.","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease.","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","article-title":"Pathway paradigms revealed from the genetics of inflammatory bowel disease.","volume":"578","author":"Graham","year":"2020","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2013.11.008","article-title":"Role of the enteric microbiota in intestinal homeostasis and inflammation.","volume":"68","author":"Koboziev","year":"2014","journal-title":"Free Radic Biol Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10620-014-3350-9","article-title":"Environmental risk factors for inflammatory bowel diseases: a review.","volume":"60","author":"Ananthakrishnan","year":"2015","journal-title":"Dig Dis Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease.","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis.","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4161\/gmic.2.4.17863","article-title":"Intestinal dysbiosis in inflammatory bowel disease.","volume":"2","author":"Kaur","year":"2011","journal-title":"Gut Microbes."},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota.","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing.","volume":"464","author":"Qin","year":"2010","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MOG.0b013e3282f2b0e8","article-title":"Gastrointestinal microbiology enters the metagenomics era.","volume":"24","author":"Frank","year":"2008","journal-title":"Curr Opin Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome.","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora.","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science."},{"key":"B20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/gutjnl-2011-301805","article-title":"A metagenomic insight into our gut\u2019s microbiome.","volume":"62","author":"Lepage","year":"2013","journal-title":"Gut."},{"key":"B21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cmet.2019.05.002","article-title":"Nutrient sensing in CD11c cells alters the gut microbiota to regulate food intake and body mass.","volume":"30","author":"Chagwedera","year":"2019","journal-title":"Cell Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota.","volume":"478","author":"Lathrop","year":"2011","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2016.11.003","article-title":"Microbiota diurnal rhythmicity programs host transcriptome oscillations.","volume":"167","author":"Thaiss","year":"2016","journal-title":"Cell."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1177486","article-title":"Bacterial community variation in human body habitats across space and time.","volume":"326","author":"Costello","year":"2009","journal-title":"Science."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","article-title":"A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.","volume":"139","author":"Willing","year":"2010","journal-title":"Gastroenterology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/MIB.0000000000000036","article-title":"Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn\u2019s disease.","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","article-title":"Microbial genes and pathways in inflammatory bowel disease.","volume":"17","author":"Schirmer","year":"2019","journal-title":"Nat Rev Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071371","article-title":"Gut microbiome in inflammatory bowel disease: role in pathogenesis, dietary modulation, and colitis-associated colon cancer.","volume":"10","author":"Gubatan","year":"2022","journal-title":"Microorganisms."},{"key":"B30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ame2.12262","article-title":"Research progress on the relationship between intestinal microecology and intestinal bowel disease.","volume":"5","author":"Fu","year":"2022","journal-title":"Animal Model Exp Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature18849","article-title":"Interactions between the microbiota and pathogenic bacteria in the gut.","volume":"535","author":"B\u00e4umler","year":"2016","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/ibd.20993","article-title":"Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.","volume":"15","author":"Braun","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"B33","first-page":"180","article-title":"The causes of intestinal dysbiosis: a review.","volume":"9","author":"Hawrelak","year":"2004","journal-title":"Altern Med Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1128\/CDLI.11.3.581-587.2004","article-title":"Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.","volume":"11","author":"Schultz","year":"2004","journal-title":"Clin Diagn Lab Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gut.33.5.646","article-title":"Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.","volume":"33","author":"Giaffer","year":"1992","journal-title":"Gut."},{"key":"B37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bmj.297.6641.102","article-title":"Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.","volume":"297","author":"Burke","year":"1988","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.chom.2012.10.012","article-title":"Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications.","volume":"12","author":"B\u00e4ckhed","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13419","article-title":"Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn\u2019s disease.","volume":"7","author":"Mottawea","year":"2016","journal-title":"Nat Commun."},{"key":"B40","doi-asserted-by":"crossref","first-page":"G216","DOI":"10.1152\/ajpgi.2001.281.1.G216","article-title":"Inflammatory bowel disease is associated with changes of enterocytic junctions.","volume":"281","author":"Gassler","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MEG.0000000000000581","article-title":"Persisting changes of intestinal microbiota after bowel lavage and colonoscopy.","volume":"28","author":"Drago","year":"2016","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease.","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/j.gastro.2016.07.008","article-title":"Inflammation and the intestinal barrier: leukocyte-epithelial cell interactions, cell junction remodeling, and mucosal repair.","volume":"151","author":"Luissint","year":"2016","journal-title":"Gastroenterology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/sj.bjp.0705682","article-title":"Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids.","volume":"141","author":"Huuskonen","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.clnu.2010.04.002","article-title":"Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.","volume":"29","author":"Hamer","year":"2010","journal-title":"Clin Nutr."},{"key":"B47","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion.","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science."},{"key":"B48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1172\/JCI62236","article-title":"NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.","volume":"123","author":"Couturier-Maillard","year":"2013","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gutjnl-2018-317855","article-title":"Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.","volume":"69","author":"Torres","year":"2020","journal-title":"Gut."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18014-5","article-title":"A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself.","volume":"7","author":"Gomes-Neto","year":"2017","journal-title":"Sci Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/femsre\/fuy003","article-title":"Pathogens, microbiome and the host: emergence of the ecological Koch\u2019s postulates.","volume":"42","author":"Vonaesch","year":"2018","journal-title":"FEMS Microbiol Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfil Koch\u2019s postulates for pyloric Campylobacter.","volume":"142","author":"Marshall","year":"1985","journal-title":"Med J Aust."},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4161\/gmic.2.1.14651","article-title":"Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model.","volume":"2","author":"Becker","year":"2011","journal-title":"Gut Microbes."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00555","article-title":"Mechanisms of microbe-host interaction in crohn\u2019s disease: dysbiosis vs. pathobiont selection.","volume":"6","author":"Butt\u00f3","year":"2015","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004911","article-title":"Surface-associated lipoproteins link enterococcus faecalis virulence to colitogenic activity in IL-10-deficient mice independent of their expression levels.","volume":"11","author":"Ocvirk","year":"2015","journal-title":"PLoS Pathog."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1128\/IAI.01513-13","article-title":"Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-\/- mice.","volume":"82","author":"Eun","year":"2014","journal-title":"Infect Immun."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice.","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science."},{"key":"B58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ibd\/izx014","article-title":"Differential susceptibility to T cell-induced colitis in mice: role of the intestinal microbiota.","volume":"24","author":"Reinoso Webb","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/gutjnl-2015-309333","article-title":"Dysbiotic gut microbiota causes transmissible Crohn\u2019s disease-like ileitis independent of failure in antimicrobial defence.","volume":"65","author":"Schaubeck","year":"2016","journal-title":"Gut."},{"key":"B60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00054725-200201000-00002","article-title":"Preliminary study of ciprofloxacin in active Crohn\u2019s disease.","volume":"8","author":"Arnold","year":"2002","journal-title":"Inflamm Bowel Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/apt.12688","article-title":"Adjunct antibiotic combination therapy for steroid-refractory or-dependent ulcerative colitis: an open-label multicentre study.","volume":"39","author":"Kato","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"B62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000358141","article-title":"Is rifaximin effective in maintaining remission in Crohn\u2019s disease?.","volume":"32","author":"Jigaranu","year":"2014","journal-title":"Dig Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00004836-198908000-00008","article-title":"A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.","volume":"11","author":"Gilat","year":"1989","journal-title":"J Clin Gastroenterol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/etm.2012.718","article-title":"Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease.","volume":"4","author":"Wang","year":"2012","journal-title":"Exp Ther Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.crohns.2014.05.010","article-title":"Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.","volume":"8","author":"Turner","year":"2014","journal-title":"J Crohns Colitis."},{"key":"B68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.crohns.2011.01.006","article-title":"Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn\u2019s disease.","volume":"5","author":"Levine","year":"2011","journal-title":"J Crohns Colitis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/gutjnl-2012-303184","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.","volume":"62","author":"P\u00e9rez-Cobas","year":"2013","journal-title":"Gut."},{"key":"B70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/gmic.27128","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.","volume":"5","author":"Ferrer","year":"2014","journal-title":"Gut Microbes."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.","volume":"125","author":"Gibson","year":"1995","journal-title":"J Nutr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.clnu.2010.05.005","article-title":"The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats.","volume":"29","author":"Rodr\u00edguez-Cabezas","year":"2010","journal-title":"Clin Nutr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.intimp.2016.08.040","article-title":"The effects of konjac oligosaccharide on TNBS-induced colitis in rats.","volume":"40","author":"Liu","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2016.11.009","article-title":"Review of the mechanisms of probiotic actions in the prevention of colorectal cancer.","volume":"37","author":"Dos Reis","year":"2017","journal-title":"Nutr Res."},{"key":"B75","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cgh.2014.10.031","article-title":"The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn\u2019s disease.","volume":"13","author":"Fedorak","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile.","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5694\/mja17.00295","article-title":"Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.","volume":"207","author":"Moayyedi","year":"2017","journal-title":"Med J Aust."},{"key":"B79","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/19490976.2016.1277313","article-title":"Analysis of gut microbiota-an ever changing landscape.","volume":"8","author":"Sadowsky","year":"2017","journal-title":"Gut Microbes."},{"key":"B80","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation.","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0070-0","article-title":"Dynamic changes in short and long term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection.","volume":"3","author":"Weingarden","year":"2015","journal-title":"Microbiome."},{"key":"B82","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial.","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology."},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8941340","article-title":"Protocol for fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis.","volume":"2018","author":"Fang","year":"2018","journal-title":"Biomed Res Int."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2100197","article-title":"The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.","volume":"14","author":"He","year":"2022","journal-title":"Gut Microbes."},{"key":"B86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","article-title":"Adverse events in faecal microbiota transplant: a review of the literature.","volume":"92","author":"Baxter","year":"2016","journal-title":"J Hosp Infect."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161174","article-title":"Systematic review: adverse events of fecal microbiota transplantation.","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One."},{"key":"B88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/JIR.S176190","article-title":"Fecal microbiota transplant- a new frontier in inflammatory bowel disease.","volume":"11","author":"Sunkara","year":"2018","journal-title":"J Inflamm Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management.","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mib.2017.10.001","article-title":"Commensal Koch\u2019s postulates: establishing causation in human microbiota research.","volume":"42","author":"Neville","year":"2018","journal-title":"Curr Opin Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/JCM.01500-13","article-title":"Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.","volume":"52","author":"Wang","year":"2014","journal-title":"J Clin Microbiol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111684","article-title":"Isolation and characterization of potentially probiotic bacterial strains from mice: proof of concept for personalized probiotics.","volume":"10","author":"Celiberto","year":"2018","journal-title":"Nutrients."},{"key":"B93","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ibd\/izy281","article-title":"Bacteroides thetaiotaomicron ameliorates colon inflammation in preclinical models of crohn\u2019s disease.","volume":"25","author":"Delday","year":"2019","journal-title":"Inflamm Bowel Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1023896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T07:17:18Z","timestamp":1668064638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1023896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":93,"alternative-id":["10.3389\/fmed.2022.1023896"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1023896","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"1023896"}}